Type III kinase inhibitors operate as a steady state non competitive or uncompetitive inhibitor, ATP does not hinder their interaction with the target kinase augmentin adverse effects
Author
Posts
Viewing 1 post (of 1 total)
The forum ‘UdyaMe Community Forum’ is closed to new topics and replies.